CSLLY - CSL Limited falls after Phase 3 setback for key trial
2024-02-12 13:53:40 ET
More on CSL
- CSL Limited: Positive Capital Return And Earnings Growth Expectations
- Arcturus, CSL win approval for world’s first self-amplifying mRNA vaccine in Japan
- Historical earnings data for CSL
- Dividend scorecard for CSL
- Financial information for CSL